-
Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma.
J Oral Pathol Med. 2018 Apr;47(4):359-367
PMID: 29469989
-
CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma.
J Oral Pathol Med. 2016 Jul;45(6):433-9
PMID: 26661374
-
Immunohistochemical Study of PD-1/PD-L1 Axis Expression in Oral Tongue Squamous Cell Carcinomas: Effect of Neoadjuvant Chemotherapy on Local Recurrence.
Pathol Oncol Res. 2020 Apr;26(2):735-742
PMID: 30767115
-
Cancer immunoediting from immune surveillance to immune escape.
Immunology. 2007 May;121(1):1-14
PMID: 17386080
-
PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer.
Cancer Res. 2017 Nov 15;77(22):6353-6364
PMID: 28904066
-
The role of dendritic cells in cancer.
Semin Immunopathol. 2017 Apr;39(3):307-316
PMID: 27638181
-
High PD-L1 Expression Correlates with Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma.
PLoS One. 2015 Nov 12;10(11):e0142656
PMID: 26562534
-
Integrating histopathology, immune biomarkers, and molecular subgroups in solid cancer: the next step in precision oncology.
Virchows Arch. 2019 Apr;474(4):463-474
PMID: 30631935
-
Staging and grading of oral squamous cell carcinoma: An update.
Oral Oncol. 2020 Aug;107:104799
PMID: 32446214
-
Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study.
Head Neck. 2017 Feb;39(2):297-304
PMID: 27696557
-
Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: A systematic review and comprehensive meta-analysis.
Oral Oncol. 2020 Jul;106:104722
PMID: 32330687
-
PD1 signal transduction pathways in T cells.
Oncotarget. 2017 Apr 19;8(31):51936-51945
PMID: 28881701
-
Macrophages and prognosis of oral squamous cell carcinoma: A systematic review.
J Oral Pathol Med. 2018 May;47(5):460-467
PMID: 28940738
-
Tumor-infiltrating CD8+ T-cell density is an independent prognostic marker for oral squamous cell carcinoma.
Cancer Med. 2019 Jan;8(1):80-93
PMID: 30600646
-
Hallmarks of cancer: the next generation.
Cell. 2011 Mar 4;144(5):646-74
PMID: 21376230
-
Immunology and Immunotherapy of Head and Neck Cancer.
J Clin Oncol. 2015 Oct 10;33(29):3293-304
PMID: 26351330
-
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma.
Head Neck. 2016 Jul;38(7):1074-84
PMID: 26879675
-
Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma.
J Dent Res. 2018 Jun;97(6):622-626
PMID: 29489423
-
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
J Immunother Cancer. 2018 Jan 23;6(1):8
PMID: 29357948
-
Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma.
BMC Clin Pathol. 2014 Aug 23;14:38
PMID: 25177210
-
Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
Br J Cancer. 2019 Apr;120(7):714-727
PMID: 30808992
-
Cancer classification using the Immunoscore: a worldwide task force.
J Transl Med. 2012 Oct 03;10:205
PMID: 23034130
-
Oral squamous cell carcinoma overview.
Oral Oncol. 2009 Apr-May;45(4-5):301-8
PMID: 19249237
-
The immune microenvironment of human tumors: general significance and clinical impact.
Cancer Microenviron. 2013 Aug;6(2):117-22
PMID: 23108700
-
Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis.
J Oral Pathol Med. 2017 Nov;46(10):928-933
PMID: 28585308
-
Effects of Tobacco Smoking on the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
Clin Cancer Res. 2020 Mar 15;26(6):1474-1485
PMID: 31848186
-
Clinicopathological and prognostic significance of PD-1/PD-L1 axis expression in patients with tongue squamous cell carcinoma.
J Cell Physiol. 2020 Oct;235(10):6942-6953
PMID: 32030768
-
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.
Ann Surg Oncol. 2010 Jun;17(6):1471-4
PMID: 20180029
-
PD-L1 expression patterns in oral cancer as an integrated approach for further prognostic classification.
Oral Dis. 2020 Nov 10;:
PMID: 33169454
-
An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.
Int J Cancer. 2016 Jun 15;138(12):2952-62
PMID: 26815146
-
Immune Response Against Head and Neck Cancer: Biological Mechanisms and Implication on Therapy.
Transl Oncol. 2020 Feb;13(2):262-274
PMID: 31869751
-
Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer.
Cancer Med. 2012 Oct;1(2):128-40
PMID: 23342263
-
Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
Int J Cancer. 2020 Feb 15;146(4):1152-1163
PMID: 31304591
-
Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol. 2020 Jun;150:102966
PMID: 32371338
-
PD-L1 Expression in Tumor Cells Is an Independent Unfavorable Prognostic Factor in Oral Squamous Cell Carcinoma.
Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):546-554
PMID: 30487133
-
CD20+ Tumor Infiltrating B Lymphocyte in Oral Squamous Cell Carcinoma: Correlation with Clinicopathologic Characteristics and Heat Shock Protein 70 Expression.
Patholog Res Int. 2018 Apr 4;2018:4810751
PMID: 29850009
-
Characteristics and impact of programmed death-ligand 1 expression, CD8+ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma.
Med Oncol. 2019 Jan 21;36(2):21
PMID: 30666437
-
The hallmarks of cancer.
Cell. 2000 Jan 7;100(1):57-70
PMID: 10647931
-
Immune suppressive mechanisms in the tumor microenvironment.
Curr Opin Immunol. 2016 Apr;39:1-6
PMID: 26609943
-
A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma.
Histopathology. 2018 May;72(6):905-913
PMID: 29023924
-
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2018 Nov;68(6):394-424
PMID: 30207593
-
Depletion of Langerhans cells in the tongue from patients with advanced-stage acquired immune deficiency syndrome: relation to opportunistic infections.
Histopathology. 2012 Feb;60(3):497-503
PMID: 22168427
-
Insights into the role of components of the tumor microenvironment in oral carcinoma call for new therapeutic approaches.
Exp Cell Res. 2014 Jul 15;325(2):58-64
PMID: 24462456
-
Inflammatory breast cancer biology: the tumour microenvironment is key.
Nat Rev Cancer. 2018 Aug;18(8):485-499
PMID: 29703913